|
Price List
Marker List
|
|
STRP Genotyping
Project Information
Requirements for Samples:
DNA:
-
All samples should be diluted with filter sterilized
distilled or deionized water to a concentration of 20-30 ng/µl.
Do not use TE! The residual EDTA will negatively impact the small
volume multiplexed PCR reactions that we perform for genotyping. If
the dilutions of the samples are such that the residual EDTA concentration
exceeds 0.05 mM we need to know that. The volume needed for your specific
project will be communicated to you through email since the amount
will vary by project depending upon the number of markers.
-
It is recommended that you retain some concentrated
stock for each sample to use in subsequent studies and also in the
event we require additional DNA to supplement weakly amplifying samples.
-
Please contact us before sending DNA acquired via
buccal swab methods. We have had mixed results in the past with low
amounts of buccal DNA. DNA obtained from the MDA reaction is an acceptable
template for STRP analysis.
-
If needed we can provide DNA extraction and reagent
protocols. Alternatively we can provide that service at PreventionGenetics
along with Biobanking services.
Sample Tubes, Labeling and Shipping:
-
We will send you labeled tubes, racks, and plate
seals for your samples after we receive your datafile (see below).
To ship the tubes, we will need the address and phone number of a
contact person.
-
The datafile entries should contain the kindred
and individual number, Father ID, Mother ID and Gender. No patient
identification information (such as names, social security numbers,
or phenotypic status) should be provided. Kindred numbers and individual
numbers should be kept as simple as possible. These two numbers will
be used on the tube labels. Do NOT use any letters or hyphenated numbers
in the kindred or individual identification numbers. Our programs
do not accept alphanumeric character strings. If there is a unique
lab ID that you would like included on the tubes please add that identifier
in the LabID column on the spreadsheet. If provided that identifier
will be included on the tube label. The datafile can be returned via
email to dave.vaske@preventiongenetics.com.
-
When your samples are ready for shipping they should
be frozen to -80oC. At that time also freeze enough ice packs to -80
degrees C to fill the Styrofoam shipping container. Once everything
is frozen to -80 degrees C pack the samples and ice packs tightly
into the container and send the shipment via overnight delivery to:
PreventionGenetics
Attn: David Vaske
3700 Downwind Drive
Marshfield, WI 54449
Phone: 715-387-0484
Requirements for Data Information:
Our programs will not accept alphanumeric, decimal or hyphenated numbers.
There should be NO entries in the Individual column for samples that will
not have DNA to be genotyped. Note also this file contains plate and well
location for your samples. The returned file will be used for database and
project set-up as well as to determine the number of samples for the final
genotyping invoice.
It is asked that the following fields of information be completed within
an Excel spreadsheet:
- The kindred (family) number for each sample donor.
- The individual number for each sample donor (required).
- The individual numbers of both the father and mother of the
sample donor if possible.
- The gender of the sample donor, (1 for male and 2 for female;
required).
- Unique LabID, if desired and useful for your purposes.
An example of this data file is listed below:
Plate |
Well |
Kindred ID |
Individual ID |
Father ID |
Mother ID |
Gender |
1 |
A01 |
1 |
302 |
0 |
0 |
1 |
1 |
A02 |
1 |
101 |
0 |
0 |
2 |
1 |
A03 |
1 |
402 |
302 |
101 |
1 |
1 |
A04 |
1 |
403 |
302 |
101 |
2 |
1 |
A05 |
1 |
404 |
302 |
101 |
1 |
1 |
A06 |
1 |
503 |
0 |
0 |
1 |
1 |
A07 |
1 |
511 |
402 |
503 |
1 |
1 |
A08 |
1 |
512 |
402 |
503 |
2 |
1 |
A09 |
1 |
513 |
402 |
503 |
1 |
1 |
A10 |
1 |
607 |
712 |
713 |
1 |
1 |
A11 |
1 |
612 |
607 |
403 |
1 |
1 |
A12 |
1 |
613 |
607 |
403 |
2 |
1 |
B01 |
1 |
615 |
607 |
403 |
2 |
1 |
B02 |
1 |
616 |
607 |
403 |
1 |
1 |
B03 |
1 |
617 |
607 |
403 |
1 |
Gender information will be used to identify any sample mislabeling through
typing of X and Y chromosome polymorphisms. We recommend that all samples
that come into the lab for genotyping have at least one gender specific
marker typed with them! Family structures are used to search for violation
of Mendel's segregation rules as a final check of the genotyping results.
If your project is such that family structure does not exist, make certain
each individual has a unique ID and leave the father and mother cells
empty.
Currently, the maximum number of individuals for any one family is 86.
If you have a family that is larger than 86 individuals, you will need
to break the family down into two or more branches. Please give each branch
a different family number. Family members need to be contiguous on a plate
unless the sample number and start location for a family causes that family
to get split across adjacent plates.
Genotyping Results:
The full address including email address and phone number of the individual
who will receive the genotyping results should be sent to PreventionGenetics
at the time of sample submission. Upon project completion, initial genotyping
data will be sent via email to this individual. Once completed the final
reports will be cut to a CD and sent via mail to the PI. Genotyping data
will also be cut to the CD.
Genotyping results will be reported to you as allele sizes of the polymorphic
markers in nucleotides. Allele sizes for all test samples are determined
relative to the allele sizes assigned to the parents of CEPH family 1331
(133101 and 133102). Amplified DNA from these two individuals is used as
standards on all of our gels. Reference genotypes for these two individuals
for most markers may be obtained from the Center for Medical Genetics web
site http://research.marshfieldclinic.org/genetics. Note that there may
be differences between the sizes assigned to alleles and the actual physical
lengths of the amplified fragments. However, in nearly all cases these differences
will be no more than a few nucleotides. Note also that alleles with the
same electrophoretic mobility will occasionally differ in sequence. For
example, an allele with 18 dinucleotide repeats with structure (AC)10(TC)8
will be indistinguishable from an allele with (AC)8(TC)10 structure.
Genotyping results will be reported by chromosome and physical marker location
along the chromosome. Thus a genome scan will have 26 excel files with genotyping
data. Fine mapping projects will vary in file number depending upon the
number of regions included in the project.
In the genotyping data files each marker is allotted four columns. These
columns contain from left to right: allele 1 (larger allele in heterozygotes),
allele 2, quality (either 0.99 or 0.90), and flag or indicator. The five
indicators are:
- ' * ' - for putative mutation
(violation of Mendel's rules given the family structure which you provided)
- ' &' - three or more alleles,
- ' $ ' -
heterozygotes in which one of the two alleles was noticeably stronger
than the other
- ' @ ' - gender error
- ' N ' - non-integer alleles (alleles which differ
in length from other frequent alleles by a value other than an integer
multiple of the repeat length).
Genotyping Quality:
Quality values (also known as confidence values) of 0.90 or 0.99 will
be attached to each genotype for which we can determine alleles. Most genotypes
will have quality values of 0.99; a few will be assigned the 0.90 values.
The quality values are crude estimates of the probability that each genotype
is correct. Analysts will have the choice of choosing quality value cutoffs
for the data. For example, analysis programs may be run both excluding and
including the 0.90 quality value genotypes. Goals for our large-scale genotyping
efforts are > 95% average completeness of the genotyping data and <
1%genotype errors.
Completeness and quality of the genotyping data is highly dependent upon
the DNA sample quality. If DNA samples are at the wrong concentration or
are contaminated with materials which interfere with PCR, these samples
will likely give poor results. We will identify samples which consistently
amplified poorly at the end of the project. |
|